Cytocentric Visionaries: Dr. David Gozal, MD Part 2: COVID-19 Research, Prone Positioning, and Chronoadequacy Alicia Henn, PhD MBA, Chief Scientific Officer, BioSpherix David Gozal, MD, MBA, PhD (Hon) is the Marie M. and Harry L. Smith Endowed Chair and Chairperson of...
Alicia Henn
Cytocentric Visionaries: Dr. David Gozal, MD – Part One
Cytocentric Visionaries: Dr. David Gozal, MD Part 1: COVID-19, ACE2, and the Circadian Clock Alicia Henn, PhD MBA, Chief Scientific Officer, BioSpherix David Gozal, MD, MBA, PhD (Hon) is the Marie M. and Harry L. Smith Endowed Chair and Chairperson of the Department...
Cytocentric Visionaries: David Lawrence
Cytocentric Visionaries: Dr. David Lawrence, University at Albany Inflammation and Oxidative Stress: Cell Conditions Matter, Even for CAR-T Dr. David A Lawrence is Professor and Chair of Environmental Health Sciences, at the School of Public...
Cytocentric Visionaries: Robert Elliott
Dr. Robert Elliott, MD PhD, is a Surgeon for Diseases and Cancer of the Breast. He is also Director of the Elliott Breast Cancer Research and Treatment Center in Baton Rouge, Louisiana....
Controlling Relative Humidity
Relative Humidity in Xvivo System Incubators New Concepts and Practices with the Risk-based Approach We are all taught to do cell biology in room air conditions with room air CO2 incubators. This is technology that hasn’t changed in 60 years. We filled up...
Death to Cleanrooms
Death to Cleanrooms Cleanrooms can be eliminated for biopharmaceutical manufacturing, if the goal of 100% closed processing can be achieved. Learn why properly conditioned isolators are replacing cleanrooms. This bold statement is from Pharma’s Almanac...
Cytocentric Visionaries: Adrien Moya p2
Cytocentric Visionaries: Dr. Adrien Moya, University of Miami Part 2: Focusing on Cell Fate In Part One of this two-part interview, we talk with Dr. Moya about his recent paper on the importance of proper glucose and oxygen levels for MSC in...
Cytocentric Visionaries: Adrien Moya p1
Cytocentric Visionaries: Dr. Adrien Moya, University of Miami Part 1: Oxygen and Glucose for Engineering Tissues Dr. Adrien Moya has just started a post-doc at the University of Miami in the lab of Paul Schiller. Here we discuss Dr. Moya’s...
Cytocentric Visionaries Budd Tucker p2
Cytocentric Visionary: Budd Tucker, University of Iowa Part 2: Modularity is Key to Cell Therapy Process Flexibility Dr. Budd Tucker is the Stephen A. Wynn Associate Professor of Regenerative Ophthalmology at the Stephen A. Wynn...
Cytocentric Visionaries Budd Tucker p1
Cytocentric Visionary: Budd Tucker, University of Iowa With iPSC and CRISPR, Leave Nobody Behind, Leave Nobody Blind Dr. Budd Tucker is the Stephen A. Wynn Associate Professor of Regenerative Ophthalmology at the Stephen A. Wynn...